Supply chain mastery can redefine your market position. How are you optimizing operations? Explore the 3 lessons for Pharma from Amazon. — https://lnkd.in/dg5FHeRP https://lnkd.in/dFr4vJCS #amazon #lessonsforpharma #knowledgeatthecenter #heretohealth #theGenH
Info
Based in Basel, the heart of European pharmaceutical innovation, GenH is uniquely positioned to drive the future of healthcare. We combine deep industry expertise with cutting-edge insights from biotech startups and executive education to deliver exceptional strategic consulting and advisory services. Founded by Daniel Guedelha, a seasoned industry leader with 16 years of experience at Novartis, GenH leverages strategic partnerships with top universities to offer a comprehensive suite of services. Our offerings include tailored strategic consulting, targeted advisory for biotech startups, executive education programs, and personalized mentorship - all designed to empower leaders and organizations to achieve transformative change. At GenH, we recognize that even the most promising generations can fall short without the right resources, mentorship, and collaboration. That’s why we bridge the gap, connecting the brightest minds with the largest companies, to turn potential into actionable impact. Our holistic approach ensures that talent is not only nurtured but empowered to lead and innovate within the healthcare and pharmaceutical industries.
- Website
-
thegenh.com
Externer Link zu GenH
- Branche
- Unternehmensberatung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Basel
- Art
- Privatunternehmen
- Gegründet
- 2024
Orte
-
Primär
GenH Basel
Basel, 4055, CH
Beschäftigte von GenH
Updates
-
#GenerationHealthSpeaks with Guillermo on the crucial mindset change that biotech companies need to undergo when transitioning from preclinical to clinical stages. Preclinical companies are often led by academic founders or CSOs focused on the science and fundraising, but as they move toward an IND filing and clinical development, their strategy must shift. Guillermo discusses how companies need to start planning for partnerships with Big Pharma, particularly for later-stage development and phase three trials, and how to prepare for potential exits or out-licensing of assets. Guillermo Tramontin is an Executive Search Specialist and Portfolio Builder for VCs at Cavenagh Health, helping VC-backed companies in life sciences, biopharma, medtech, and digital health build world-class leadership teams focused on real patient impact. #GenerationHealthSpeaks #BiotechTransition #ClinicalDevelopment #VCImpact #HealthcareInnovation #TheGenH Daniel Guedelha
-
#knowledgeatthecenter In healthcare, we're often told that innovation requires a complete overhaul – but does it really? Think of Spotify: it didn’t kill radio, but it changed how we experience music by creating something new, personalized, and flexible, all within an existing system. The healthcare industry faces a similar challenge today. Can we reshape patient care from the inside, or is it time to tear everything down? With the rise of digital health, telemedicine, and value-based care, the tools to transform healthcare are already in place. But rather than starting from scratch, we can take inspiration from other industries and evolve the system, offering better patient outcomes and aligning costs with results, without abandoning what works. Like Spotify with music, healthcare can revolutionize the experience without dismantling the foundation. #heretohealth #theGenH #HealthcareInnovation #DigitalHealthRevolution #PatientCareTransformation
-
Thank you Anna Mulock Houwer.
𝐓𝐡𝐚𝐧𝐤 𝐲𝐨𝐮 𝐬𝐨 𝐦𝐮𝐜𝐡 𝐟𝐨𝐫 𝐲𝐨𝐮𝐫 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐟𝐮𝐥 𝐜𝐨𝐦𝐦𝐞𝐧𝐭, Anna Mulock Houwer! 🙏✨💡 GenH will keep listening and learning from you and all other leaders; please share for a 𝐧𝐞𝐰, 𝐛𝐞𝐭𝐭𝐞𝐫, and 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 healthcare space! 🙂 Riverbank Advisors, Just Hotter, American Club of Lisbon, European Women on Boards (EWOB), Simona Skerjanec, Suzana Sacirovic, Hélder Romão, Sérgio Teixeira, Antonio Martin MD PhD, Anil Saggi, CFA, Dr. Sanja Tomovska, Eva Martins
-
#GenerationHealthSpeaks with Guillermo on the changing landscape of biotech IPOs, especially in the US. Once a common route for funding, IPOs and SPACs have become rare in recent years. As the market slowly recovers, companies are finding new ways to secure funding, particularly by bringing pharmaceutical companies into the development process earlier as true partners. Guillermo highlights how this approach is helping companies move forward and access the capital needed for critical trials, like phase three. Guillermo Tramontin is an Executive Search Specialist and Portfolio Builder for VCs at Cavenagh Health, helping VC-backed companies in life sciences, biopharma, medtech, and digital health build world-class leadership teams focused on real patient impact. What do you think? Drop your questions and thoughts in the comments below! Let’s continue the conversation. #GenerationHealthSpeaks #BiotechFunding #IPOChallenges #VCImpact #HealthcareInnovation #TheGenH
-
Adaptation is crucial for survival. How is your organization staying ahead of industry trends? Explore the 3 lessons for Pharma from Eastman Kodak Company. — https://lnkd.in/evH9Gpvc https://lnkd.in/dpzP_wDN #kodak #lessonsforpharma #knowledgeatthecenter #heretohealth #theGenH
-
#GenerationHealthSpeaks with Guillermo on the unique challenges that biotech founders, especially academic and first-time executives, face when building their teams. As a nurturing talent partner, Cavenagh Health plays a crucial role, not only in building teams but also in helping CEOs fundraise, shape their culture, and strategize their growth from pre-seed to Series B/C stages. Guillermo explains how they support founders in navigating the complex landscape of team building and scaling for success. Guillermo Tramontin is an Executive Search Specialist and Portfolio Builder for VCs at Cavenagh Health, helping VC-backed companies in life sciences, biopharma, medtech, and digital health build world-class leadership teams focused on real patient impact. What do you think? #GenerationHealthSpeaks #BiotechFounders #TeamBuilding #VCImpact #HealthcareInnovation #GenH
-
#shakeofperspectives In this article, co-authors Daniel Guedelha and André Coelho explore the transformation of go-to-market strategies in healthcare and pharma. Facing new challenges, companies in the industry are rethinking traditional models to deliver more innovative solutions to patients and providers. Read it now and discover how healthcare's market approach is evolving! #HealthcareInnovation #GoToMarketStrategy #HealthcareTransformation #IndustryTrends #TheGenH
-
Our founder, Daniel Guedelha is shaking perspectives. In this first Special Edition of 𝐃𝐢𝐠𝐠 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚: Shake of Perspectives, co-authored with André Coelho they dive into how go-to-market strategies are transforming healthcare and pharma. Don’t miss out - Subscribe now for monthly insights: https://lnkd.in/ddZvuc6x
I’m thrilled to introduce a Special Edition of the 𝐃𝐢𝐠𝐠 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚 newsletter: 𝐒𝐡𝐚𝐤𝐞 𝐨𝐟 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐬. This segment spotlights diverse voices from across the healthcare and pharmaceutical industries, offering fresh insights on evolving themes. Each edition will delve into key topics that are shaping the future of these industries, sparking conversations and driving innovation. In this first special edition, co-authored by me and André Coelho, we dive into how go-to-market strategies in healthcare and pharma are transforming. Launching next week! Don’t miss out! 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐧𝐨𝐰 to get new articles and fresh perspectives every month, delivered straight to your inbox. Click the link below to subscribe… Subscribe on LinkedIn https://lnkd.in/ddZvuc6x
-
#GenerationHealthSpeaks with Guillermo on how his partnership with INCATE, a Swiss company builder focused on antimicrobial therapies, led to a groundbreaking white paper. The report covered antibiotics development, phage therapeutics, microbiome therapeutics, and the current investment landscape for AMR R&D. With contributions from key players like the MENARINI Group, Shionogi & Co., Ltd, and the AMR Action Fund, this white paper made a significant impact and opened doors to major conferences like the AMR Conference 2024 in Basel. Guillermo Tramontin is an Executive Search Specialist and Portfolio Builder for VCs at Cavenagh Health, helping VC-backed companies in life sciences, biopharma, medtech, and digital health build world-class leadership teams focused on real patient impact. What do you think? Drop your questions and thoughts in the comments below! Let’s continue the conversation. #GenerationHealthSpeaks #AMRInnovation #VCImpact #AntimicrobialTherapies #HealthcareInnovation #TheGenH